source
- Senate introduces BINSA bill to tighten review of China biotech and pharma transactionsThe U.S. Senate has introduced the Biotech Innovation and National Security Act (BINSA), a bill that would tighten oversight of biotech and pharmaceutical transactions involving China. The proposa…
- FDA schedules September advisory panel to review Grail's cancer test after trial missThe FDA announced it will hold an advisory committee meeting in September to examine Grail's multi‑cancer early detection test. The test recently failed to meet its primary endpoint in a large, ra…